![](/img/cover-not-exists.png)
PCN3 RITUXIMAB-BASED REGIMEN AS FRONTLINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD NATIONWIDE COHORT STUDY
Ko, B.S., Huang, H.H., Wang, C.Y., Chen, H.M., Hsiao, F.Y.S.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.200
Date:
November, 2019
File:
PDF, 387 KB
2019